Baxter Runs With Cheetah Medical In $230M Deal
Executive Summary
Baxter International is buying Israeli company Cheetah Medical in a $230m deal. The acquisition expands Baxter’s portfolio of medication delivery products.
You may also be interested in...
Baxter Reports $45M Boost From COVID-19 Demand In Q1
The COVID-19 pandemic has increased demand for products from all of Baxter’s businesses except its advanced surgery division. Overall, the diversified company’s global sales were up 8% in the first quarter.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.